Attention A T users. To access the menus on this page please perform the following steps. 1. Please switch auto forms mode to off. 2. Hit enter to expand a main menu option (Health, Benefits, etc). 3. To enter and activate the submenu links, hit the down arrow. You will now be able to tab or arrow up or down through the submenu options to access/activate the submenu links.

Viral Hepatitis

Menu
Menu

Quick Links

Veterans Crisis Line Badge
My healthevet badge
EBenefits Badge
 

Hepatitis C Treatment Considerations

for Veterans and the Public

Chronic Hepatitis C Virus (HCV) Infection: Treatment Considerations

Contents

For the full PDF version, click here

Introduction

This revision (March 28, 2016) incorporates updates to treatment regimens for chronic hepatitis C virus (HCV) infection, genotype 1, 2, 3, or 4. The Introduction has been revised to include a new section titled "Interpretation of Resistance Associated Polymorphisms." Additional revisions include updates on drug-drug interactions to provide clinicians with guidance on the concomitant use of HCV drugs and other drugs, including HIV antiretroviral agents (Appendix A, Tables A4 and A5). Information on HCV resistance genotyping and sample reports have been included (Appendices B and C). The Panel continues to recommend that HIV/HCV-coinfected patients receive the same HCV antiviral regimens as HCV-monoinfected patients.